• 1
    Tohen M, McDonnell DP, Case M et al. Randomized, double-blind, placebo-controlled study of olanzapine in patients with bipolar I depression. Br. J. Psychiatry 2012; 201: 376382.
  • 2
    Katagiri H, Tohen M, McDonnell DP et al. Efficacy and safety of olanzapine for treatment of patients with bipolar depression: Japanese subpopulation analysis of a randomized, double-blind, placebo-controlled study. BMC Psychiatry 2013; 13: 138.
  • 3
    Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 1960; 23: 5662.
  • 4
    Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of The National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001; 285: 24862497.
  • 5
    American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2013; 36 (Suppl. 1): S67S74.
  • 6
    Montgomery SA, Åsberg M. A new depression scale designed to be sensitive to change. Br. J. Psychiatry 1979; 134: 382389.
  • 7
    Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: Reliability, validity and sensitivity. Br. J. Psychiatry 1978; 133: 429435.
  • 8
    Tohen M, Frank E, Bowden CL et al. The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders. Bipolar Disord. 2009; 11: 453473.
  • 9
    Zyprexa [package insert]. Eli Lilly and Company, Indianapolis, IN, 2011.
  • 10
    Millen BA, Campbell GM, Beasley CM. Weight changes over time in adults treated with the oral or depot formulations of olanzapine: A pooled analysis of 86 clinical trials. J. Psychopharmacol. 2011; 25: 639645.
  • 11
    Lieberman JA, Stroup TS, McEvoy JP et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N. Engl. J. Med. 2005; 353: 12091223.
  • 12
    Kryzhanovskaya LA, Xu W, Millen BA, Acharya N, Jen KY, Olawale O. Comparison of long-term (at least 24 weeks) weight gain and metabolic changes between adolescents and adults treated with olanzapine. J Child Adolesc Psychopharmacol. 2012; 22: 157165.
  • 13
    Tohen M, Zarate CA Jr, Hennen J et al. The McLean-Harvard First-Episode Mania Study: Prediction of recovery and first recurrence. Am. J. Psychiatry 2003; 160: 20992107.